No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Atul Ltd is a prominent global manufacturer and distributor, offering an extensive portfolio of chemical products. The company strategically organizes its operations across two primary divisions: Life Science Chemicals, and Performance and Other Chemicals. Its comprehensive product offerings encompass a vast array of compounds, including numerous aromatics such as cresol mixtures, allyl caproate, phenyl acetic acid, and anisyl alcohol. It also supplies a wide range of bulk chemicals and intermediates, including essential industrial materials like caustic soda lye, hydrochloric acid, sulphuric acid, hydrogen gas, resorcinol, and oleum. Further diversifying its output, Atul Ltd provides various colorants, a full suite of agrochemicals (such as fungicides, herbicides, and insecticides), and critical pharmaceutical building blocks, including amino acid derivatives, active pharmaceutical ingredients (APIs) and their intermediates, and phosgene derivatives. The company is also a key producer of epoxy-based solutions, offering resins, curing agents, reactive diluents, and catalysts. Beyond conventional chemicals, Atul Ltd is involved in the cultivation of tissue culture-raised oil and date palm plants. It also operates retail ventures focused on crop protection products and polymers. The versatility of Atul's products allows it to serve an exceptionally broad spectrum of industries worldwide. Its clientele spans sectors such as agriculture, automotive, pharmaceuticals, textiles, food and flavor, personal care, paints and coatings, construction, and electronics, among many others. Established in 1947, Atul Ltd has its corporate headquarters situated in Valsad, India.
www.atul.co.inNo one on the platform currently holds ATUL.NS.
No tracked institution reports a position in ATUL.NS as of their last filing.
No one on the platform has traded ATUL.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.6% | 21.3% | 28.7% | — | — | — |
| Rev. Growth % | 12.4% | 10.9% | ||||
| Profit Margin % | 10.8% | 9.5% | 11.2% | |||
| Free Cash Flow Margin % | 14.2% | 2.7% | 5.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $71.6B | +14.3% | $276.95 | $219.13–$318.90 | — | 12 |
| 2028 | $79.3B | +10.7% | $335.14 | $264.96–$377.99 | — | 12 |
| 2029 | $85.2B | +7.4% | $348.05 | $333.39–$371.32 | — | 9 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-24 | $57.00 | $83.31 | +46.2% |
| 2026-04-24 | $60.13 | $66.20 | +10.1% |
| 2026-01-23 | $55.50 | $61.87 | +11.5% |
| 2025-10-17 | $48.70 | $60.88 | +25.0% |
| 2025-07-18 | $47.05 | $43.40 | -7.8% |
| 2025-04-25 | $43.76 | $43.00 | -1.7% |
| 2025-01-24 | $39.95 | $36.90 | -7.6% |
| 2024-10-25 | $41.67 | $46.47 | +11.5% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ATUL.NSAtul Ltd | $6081.50 | -2.61% | $179.1B | — |
| AKZOINDIA.BOAkzo Nobel India Limited | $2985.85 | +0.26% | $136.0B | — |
| AKZOINDIA.NSAkzo Nobel India Limited | $2986.80 | +0.00% | $136.0B | — |
| BASF.BOBASF India Limited | $3542.05 | -3.47% | $153.4B | — |
| BASF.NSBASF India Limited | $3539.40 |
| -3.33% |
| $153.2B |
| — |
| DCMSHRIRAM.BODCM Shriram Limited | $985.65 | -1.44% | $153.9B | — |
| DCMSHRIRAM.NSDCM Shriram Limited | $994.10 | -0.59% | $155.0B | — |
Source: Financial Modeling Prep · peers by sector/industry